The following 22 images provide visual information about the product associated with Tobramycin NDC 59651-129 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1: Relative Change from Baseline in FEV1% Predicted - tobramycin fig1
Figure H - tobramycin fig10
Figure I - tobramycin fig11
Figure J - tobramycin fig12
Figure K - tobramycin fig13
Figure L - tobramycin fig14
Figure M - tobramycin fig15
Figure N - tobramycin fig16
Figure O - tobramycin fig17
Figure P - tobramycin fig18
Figure Q - tobramycin fig19
Figure 2: Absolute Change from Baseline in Log10 CFUs - tobramycin fig2
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 300 mg per 5 mL - Pouch Label (4 Single-Dose Ampules) - tobramycin fig20
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 300 mg per 5 mL - Container-Carton (56 Single-Dose Ampules) - tobramycin fig21
Figure A - tobramycin fig3
Figure B - tobramycin fig4
Figure C - tobramycin fig5
Figure D - tobramycin fig6
Figure E - tobramycin fig7
Figure F - tobramycin fig8
Figure G - tobramycin fig9
Chemical Structure - tobramycin str